Geron hires new CFO after awarding bonus to outgoing CFO

A second Geron Corp. executive who had received a six-figure 2011 bonus late last month has left the drug-development company.
Menlo Park-based Geron (NASDAQ: GERN) said Thursday that it hired Graham Cooper as chief financial officer and executive vice president of finance and business development. Cooper most recently was chief financial officer at Orexigen Therapeutics.
Cooper replaces David Greenwood, who also served as president and, for seven months last year, interim chief executive officer. When John Scarlett was named CEO in September, Geron said that Greenwood would remain with the company through the end of the year.